Fractyl Health, Inc. Common Stock (GUTS)
USD 1.9
(-5.71%)
USD 1.9
(-5.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -42.82 Million | -46.24 Million | -33.46 Million | -31.07 Million | -27.73 Million |
| Net Income | -77.09 Million | -46.45 Million | -38.73 Million | -30.48 Million | -30.59 Million |
| Depreciation & Amortization | 286 Thousand | 452 Thousand | 676 Thousand | 770 Thousand | 893 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 4.29 Million | 3.13 Million | 2.09 Million | 1.62 Million | 2.51 Million |
| Change in working capital | 989 Thousand | -1.24 Million | 1.71 Million | -3.5 Million | -824 Thousand |
| Other non-cash items | 34.08 Million | 1.9 Million | 4.23 Million | 3.68 Million | 4.57 Million |
| Investing Cash Flow | -359 Thousand | -56 Thousand | -51 Thousand | -2000.00 | -97 Thousand |
| Investments in PPE | -359 Thousand | -56 Thousand | -51 Thousand | -2000.00 | -97 Thousand |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - |
| Financing Cash Flow | 27.43 Million | 4.35 Million | 99.87 Million | 54.39 Million | 15.16 Million |
| Debt repayment | -27.94 Million | -4.02 Million | -7000.00 | -7000.00 | -14.94 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | -511 Thousand | 321 Thousand | 99.88 Million | 54.39 Million | 217 Thousand |
| Other Financing Activities | -963 Thousand | 321 Thousand | 99.88 Million | 54.39 Million | 217 Thousand |
| Accounts receivables | -22 Thousand | - | - | - | - |
| Accounts payables | -427 Thousand | 10 Thousand | 666 Thousand | -304 Thousand | - |
| Inventory | -73 Thousand | - | - | - | - |
| Other working capital | 1.51 Million | -1.24 Million | 1.71 Million | -3.5 Million | -824 Thousand |
| Cash at beginning of period | 49.26 Million | 95.47 Million | 29.1 Million | 5.79 Million | 18.45 Million |
| Cash at end of period | 33.52 Million | 49.26 Million | 95.47 Million | 29.1 Million | 5.79 Million |
| Capital Expenditure | -359 Thousand | -56 Thousand | -51 Thousand | -2000.00 | -97 Thousand |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -15.74 Million | -46.2 Million | 66.36 Million | 23.31 Million | -12.66 Million |
| Free Cash Flow | -43.18 Million | -46.29 Million | -33.51 Million | -31.07 Million | -27.82 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -17.22 Million | -3.32 Million | -19.18 Million | -77.09 Million | -15.74 Million | -30.23 Million |
| Depreciation & Amortization | 192 Thousand | 53 Thousand | 38 Thousand | 286 Thousand | 84 Thousand | 84 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 3.79 Million | 5.21 Million | 1.27 Million | 4.29 Million | 1.09 Million | 1.07 Million |
| Change in working capital | -958 Thousand | 3.42 Million | 1.19 Million | 989 Thousand | -321 Thousand | -848 Thousand |
| Other non-cash items | -1.4 Million | -12.25 Million | 7.34 Million | 34.08 Million | 2.84 Million | 18.13 Million |
| Investing Cash Flow | -260 Thousand | -1.05 Million | -136 Thousand | -359 Thousand | -148 Thousand | -55 Thousand |
| Investments in PPE | -260 Thousand | -1.05 Million | -136 Thousand | -359 Thousand | -148 Thousand | -55 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -5000.00 | 101 Million | -556 Thousand | 27.43 Million | 27.96 Million | 28 Thousand |
| Debt repayment | -21 Thousand | -2000.00 | -76 Thousand | -27.94 Million | -28.35 Million | -2000.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 16 Thousand | 163 Thousand | -480 Thousand | -511 Thousand | - | - |
| Other Financing Activities | 16 Thousand | 100.84 Million | -570 Thousand | -963 Thousand | 28.04 Million | - |
| Accounts receivables | -7000.00 | 7000.00 | 2000.00 | -22 Thousand | 32 Thousand | -51 Thousand |
| Accounts payables | 1.04 Million | 494 Thousand | 77 Thousand | -427 Thousand | -70 Thousand | -212 Thousand |
| Inventory | 9000.00 | - | 3000.00 | -73 Thousand | -3000.00 | - |
| Other working capital | -2 Million | 2.92 Million | 1.1 Million | 1.51 Million | -53 Thousand | 2000.00 |
| Cash at beginning of period | 121.75 Million | 33.52 Million | 44.81 Million | 49.26 Million | 32.26 Million | 43.95 Million |
| Cash at end of period | 102.75 Million | 121.75 Million | 33.52 Million | 33.52 Million | 49.07 Million | 32.26 Million |
| Capital Expenditure | -260 Thousand | -1.05 Million | -136 Thousand | -359 Thousand | -148 Thousand | -55 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -19 Million | 88.23 Million | -11.29 Million | -15.74 Million | 16.8 Million | -11.68 Million |
| Free Cash Flow | -18.99 Million | -12.77 Million | -10.73 Million | -43.18 Million | -11.16 Million | -11.71 Million |
BRIT3
ESSA
TRI
7649
6915
3080